Research on emerging viral infections in Sierra Leone
Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)
This study is working to make it easier for doctors and researchers in Sierra Leone to find and respond to new infections, like Ebola and Lassa Fever, so they can better protect people, animals, and farms from these health threats.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-11058539 on NIH RePORTER |
What this research studies
This research focuses on strengthening the capacity for clinical trial research and implementation science in Sierra Leone, particularly at the Kenema Government Hospital and the College of Medicine and Allied Health Sciences. It aims to improve surveillance and detection systems for emerging infections, which pose significant health threats to humans, animals, and agriculture. The project addresses the challenges posed by various infectious diseases, including Ebola, Lassa Fever, and SARS-CoV-2, by enhancing local research capabilities and infrastructure.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals in Sierra Leone who are at risk of emerging viral infections or those involved in healthcare and agricultural sectors.
Not a fit: Patients outside of Sierra Leone or those not at risk for emerging viral infections may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved detection and management of emerging viral infections, ultimately enhancing public health in Sierra Leone and similar regions.
How similar studies have performed: Other research initiatives focused on strengthening local healthcare infrastructure and surveillance systems in similar contexts have shown promise, indicating potential for success in this approach.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Schieffelin, John Scribner — Tulane University of Louisiana
- Study coordinator: Schieffelin, John Scribner
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.